Author

Andrew Jung

ORCID 0009-0007-3185-7567Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Andrew Jung2 papers · Massachusetts Eye and Ear Infirmary

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Albi CelajiD· 1 shared Bhargav KanuparthiiD· 1 shared Brandon VaziD· 1 shared Brendan J. Frey· 1 shared Chris ColeiD· 1 shared Diane LyiD· 1 shared Emma BohniD· 1 shared Farhan YusufiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Albi CelajORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

GenomicsbioRxivPreprintMay 15, 2025

Sequence based prediction of cell type specific microRNA binding and mRNA degradation for therapeutic discovery

Bhargav Kanuparthi, Sara E. Pour, Scott D. Findlay…·Brendan J. Frey

This paper introduces REPRESS, a deep learning model that predicts cell-type-specific microRNA binding and mRNA degradation from RNA sequences, outperforming existing methods in multiple tasks.

3 citations

𝕏 PostBluesky